Adenocarcinoma of unknown primary site

Patients should report any change in symptoms, whether or not they are undergoing active treatment, as this information may alter therapeutic recommendations. Patients should be actively involved in their treatment decisions, and quality of life should be paramount in contributing to those decisions.